Evidence map›Paper›PMID 42329997›Full record

ArticlePloS one2026

Direct and indirect mapping of the 12-item Short Form Survey version 2 (SF-12v2) onto the EQ-5D-5L utility scores in general Thai population.

Krittaphas Kangwanrattanakul

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Krittaphas KangwanrattanakulDivision of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Burapha University, 169 Long-Hard Bangsaen Rd, Mueang, Chonburi, Thailand.ORCID https://orcid.org/0000-0002-4921-8508

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SF-12v2 is widely used to measure health-related quality of life (HRQoL) in the general Thai population because it is brief and places a low burden on respondents. However, it does not provide utility scores required for economic analyses. The mapping approach is a solution to estimate the utility scores from the SF-12v2 response using several regression models. Therefore, this study aimed to develop a mapping algorithm to estimate EQ-5D-5L utility scores from the SF-12v2 items using a 2022 national dataset of 2000 Thai respondents. Four predictor sets incorporating SF-12v2 items/subscales and age as a covariate were investigated using direct and indirect mapping approaches. Direct mapping approaches included ordinary least squares, Tobit, censored least absolute deviations, generalized linear model (GLM), two-part models, adjusted limited dependent variable mixture model (ALDVMM), and beta mixture model, while multinomial logistic regression (MLOGIT) was investigated for indirect mapping. Model performance was evaluated using ten-fold cross-validated (post-CV) mean absolute error (MAE) and root mean square error (RMSE). The ALDVMM-1 component with a predictor set comprising age and selected SF-12 items as categorical variables demonstrated the best predictive performance, yielding the lowest post-CV MAE and RMSE (0.0410 and 0.0625, respectively). However, MLOGIT showed poorer predictive performance. Therefore, the proposed ALDVMM-1 component-based mapping algorithm may facilitate the estimation of utility scores in studies where only the SF-12v2 was collected. Given that the mapping algorithm was developed from a predominantly healthy sample, it may be less reliable in populations with poorer health status, and further validation in populations with less healthy or clinical samples is warranted in future studies.

Indexed as

Quality of LifeAdolescentAdultAgedAlgorithmsFemaleHumansMaleMiddle AgedSurveys and QuestionnairesThailandYoung Adult

Identifiers

PMID42329997
PMCPMC13286156

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.